IHME logo
Loading...

David Pigott

Associate Professor

Highly Cited Researcher 2022, ClarivateDavid Pigott, DPhil, is an Associate Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. He is a faculty member in the Geospatial team, focusing on improving the spatial resolution at which disease burden and metrics are considered, expanding and refining existing techniques to a wider number of pathogens and sequelae. He also leads work defining at-risk areas for a number of pathogens with pandemic potential and quantifying heterogeneities in global response capacity.

Dr. Pigott studied at the University of Oxford, UK, first for an undergraduate degree in Biological Sciences, then a DPhil investigating the spatial epidemiology of a variety of pathogens, including the leishmaniases and a number of zoonotic hemorrhagic fevers.

IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.

Publications

Showing 1 - 5 of 79 results
Moore M, Zhu Y, Hirsch I, et al. Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data. Epidemics. 15 April 2024. doi: 10.1016/j.epidem.2024.100768.
Sirota, SB, Doxey, MC, Dominguez, R-MV, et al. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: results from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. 9 September 2024. doi: 10.1016/S1473-3099(24)00430-4.
Harish V, Colón-González FJ, Moreira FRR, et al. Human movement and environmental barriers shape the emergence of dengue. Nature Communications. 28 May 2024. doi: 10.1038/s41467-024-48465-0.
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 16 May 2024. doi: 10.1016/S0140-6736(24)00933-4.
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 17 April 2024. doi: 10.1016/S0140-6736(24)00757-8.